Radiation burn

Global Radiodermatitis Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 14, 2022

Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer.

Key Points: 
  • Radiodermatitis, or radiation dermatitis, refers to a skin condition caused due to radiation therapy used for the treatment of cancer.
  • Key Questions Answered in This Report:
    How has the global radiodermatitis market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global radiodermatitis market?
  • What is the structure of the global radiodermatitis market and who are the key players?

Humanetics Corporation Expands Long-Haul COVID-19 Trial to Additional Sites

Retrieved on: 
Wednesday, May 18, 2022

Humanetics Corporation (Humanetics) has added two additional clinical sites to its long-haul COVID-19 study, which is focused on patients who were treated for severe COVID-19 and face the possible risk that their respiratory complications will lead to long-term impairment of lung function.

Key Points: 
  • Humanetics Corporation (Humanetics) has added two additional clinical sites to its long-haul COVID-19 study, which is focused on patients who were treated for severe COVID-19 and face the possible risk that their respiratory complications will lead to long-term impairment of lung function.
  • These sites join existing sites at NYU Langone and the Houston Methodist Research Institute.
  • The clinical study is designed to evaluate the ability of Humanetics new drug, BIO 300, to mitigate long-term pulmonary damage.
  • The primary endpoint of the trial is 12 weeks after the start of dosing and patients will be followed for one year.

Global Radiodermatitis Market to 2027 - Enormous Expansion of Healthcare Establishments Across the Globe Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 10, 2022

The "Radiodermatitis Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Radiodermatitis Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.
  • The report on the global radiodermatitis market provides qualitative and quantitative analysis for the period from 2019 to 2027.
  • The report predicts the global radiodermatitis market to grow with a CAGR of 4.43% over the forecast period from 2021-2027.
  • The report on radiodermatitis market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global radiodermatitis market over the period of 2019 to 2027.

Worldwide Radiodermatitis Industry to 2027 - by Product, Distribution Channel and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, September 23, 2021

The "Global Radiodermatitis Market to 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Radiodermatitis Market to 2027" report has been added to ResearchAndMarkets.com's offering.
  • Radiodermatitis is also referred to as X-ray dermatitis, radiation dermatitis and radiation injury.
  • The rising prevalence of cancer is a key driving factor which is expected to boost the global radiodermatitis market.
  • An increase in research and developments of new therapies for the treatment of radiodermatitis will have a positive impact on the market.

SanMelix Laboratories Wins Stevie® Award in 2021 American Business Awards® for its BEECure™ Line

Retrieved on: 
Thursday, May 20, 2021

The company\xe2\x80\x99s first product, BEECure R, is available on Amazon and Walmart.com.

Key Points: 
  • The company\xe2\x80\x99s first product, BEECure R, is available on Amazon and Walmart.com.
  • BEECure M and BEECure BH, advanced wound care dressings, are presently undergoing FDA regulatory submission.\n\xe2\x80\x9cWe are honored to have received this award and thrilled by the overwhelmingly positive reception of our BEECure products,\xe2\x80\x9d said SanMelix co-founder Diana Sabacinski, CPA, Chief Executive Officer/President (Director).
  • Its patented BEECure M product has higher anti-inflammatory and anti-oxidant properties than manuka honey-based products as well as higher standardization and broader spectrum anti-microbial activity.
  • Its over-the-counter skin products are designed to help in the healing of minor burns, scrapes, radiodermatitis and more.

Global Radiation Dermatitis Industry to 2030 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, March 29, 2021

The "Radiation Dermatitis - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Radiation Dermatitis - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The Radiation Dermatitis market report provides current treatment practices, emerging drugs, and their market share of the individual therapies, current and forecasted Radiation Dermatitis symptoms market size from 2018 to 2030 segmented by seven major markets.
  • The disease epidemiology covered in the report provides historical as well as forecasted Radiation Dermatitis symptoms epidemiology segmented as the Radiotherapy Utilization, Incidence of Radiation Dermatitis, Grade-specific cases of Radiation Dermatitis, and Treated cases of Radiation Dermatitis.
  • To understand the future market competition in the Radiation Dermatitis market and an Insightful review of the key market drivers and barriers.

Companies in Radiation Dermatitis Market Leverage Nanomaterials for Developing Novel Therapies for Wound Healing, Valuation to Touch ~US$ 700 Mn by 2030: TMR

Retrieved on: 
Tuesday, March 9, 2021

However, due to prominent absence of a common therapeutic standard, ongoing studies investigating new mechanisms of actions expand the prospect in radiation dermatitis market .

Key Points: 
  • However, due to prominent absence of a common therapeutic standard, ongoing studies investigating new mechanisms of actions expand the prospect in radiation dermatitis market .
  • Of late, non-steroidal ingredients in creams and agents for wound dressings with self-healing properties have gathered traction among companies.
  • The growing prevalence of cancers is a key trend fueling the need for wound dressings for mitigating the symptoms of radiation dermatitis.
  • The advent of new radiation therapies for cancer will shape the future contours of the radiation dermatitis market.

Companies in Radiation Dermatitis Market Leverage Nanomaterials for Developing Novel Therapies for Wound Healing, Valuation to Touch ~US$ 700 Mn by 2030: TMR

Retrieved on: 
Tuesday, March 9, 2021

However, due to prominent absence of a common therapeutic standard, ongoing studies investigating new mechanisms of actions expand the prospect in radiation dermatitis market .

Key Points: 
  • However, due to prominent absence of a common therapeutic standard, ongoing studies investigating new mechanisms of actions expand the prospect in radiation dermatitis market .
  • Of late, non-steroidal ingredients in creams and agents for wound dressings with self-healing properties have gathered traction among companies.
  • The growing prevalence of cancers is a key trend fueling the need for wound dressings for mitigating the symptoms of radiation dermatitis.
  • The advent of new radiation therapies for cancer will shape the future contours of the radiation dermatitis market.

Surging Cases of Cancer to Drive Growth of the Global Radiodermatitis Market: TMR

Retrieved on: 
Monday, January 25, 2021

A surge in the incidences of cancer worldwide is estimated to drive the growth of global radiodermatitis market over the forecast timeframe, from 2019 to 2027.

Key Points: 
  • A surge in the incidences of cancer worldwide is estimated to drive the growth of global radiodermatitis market over the forecast timeframe, from 2019 to 2027.
  • This is likely to drive the growth of the global radiodermatitis market over the analysis timeframe, from 2019 to 2027.
  • Expanding at a growth rate of ~3.3% CAGR, the global radiodermatitis market is anticipated to achieve considerable market value by 2027.
  • High cost of cancer treatment and radiation therapies is estimated to pose a threat to the development of the global radiodermatitis market.

Surging Cases of Cancer to Drive Growth of the Global Radiodermatitis Market: TMR

Retrieved on: 
Monday, January 25, 2021

A surge in the incidences of cancer worldwide is estimated to drive the growth of global radiodermatitis market over the forecast timeframe, from 2019 to 2027.

Key Points: 
  • A surge in the incidences of cancer worldwide is estimated to drive the growth of global radiodermatitis market over the forecast timeframe, from 2019 to 2027.
  • There has been augmented adoption of radiodermatitis products in an effort to better cancer patients' quality of life.
  • This is likely to drive the growth of the global radiodermatitis market over the analysis timeframe, from 2019 to 2027.
  • Expanding at a growth rate of ~3.3% CAGR, the global radiodermatitis market is anticipated to achieve considerable market value by 2027.